CureVac & GSK COVID-19 Vaccine Candidate Shows High Immunogenicity Against New Variants
CureVac N.V, a global biopharmaceutical company creating a novel class of revolutionary medicines based on messenger ribonucleic acid (mRNA), revealed
Read moreCureVac N.V, a global biopharmaceutical company creating a novel class of revolutionary medicines based on messenger ribonucleic acid (mRNA), revealed
Read moremyPOLS Biotec has developed a zero-step RT-PCR probe-based 2x Master Mix for RT-qPCR that allows immediate cycling and direct RT-PCRs.
Read moreWith the EchoLUTION viral RNA/DNA Swab Kit extracting SARS-CoV-2 viral RNA is easy. Single-step Viral SARS-CoV-2 RNA Extraction Kit for
Read moreEli Lilly and Company and MiNA Therapeutics, a pioneer in RNA activation therapeutics, have announced a worldwide research partnership to
Read moreBioEcho has received the In Vitro Diagnostic CE Mark Approval for its new SARS-CoV-2 RNA extraction kit which enables viral
Read moreFrench pharma giant Sanofi is set to acquire Tidal Therapeutics for $470m, adding the biotech’s novel mRNA-based research platform with
Read moreCureVac intends to expand its COVID-19 vaccine candidate clinical trial in order to be able to determine efficacy for select
Read morePfizer and BioNTech have published early in vitro study data showing that the BNT162b2 COVID-19 vaccine generates antibodies that neutralise
Read moreBioNTech and InstaDeep have entered into an agreement to establish a joint AI Innovation Lab in London, United Kingdom and
Read moreModerna announced today that the European Commission has approved an agreement to buy 80 million doses of mRNA-1273, Moderna’s COVID-19
Read more